Literature DB >> 8549091

A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.

M Farr1, L Waterhouse, A E Johnson, G D Kitas, R W Jubb, P A Bacon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549091     DOI: 10.1007/bf02208150

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  33 in total

1.  Therapeutic intervention in rheumatoid arthritis: a case-controlled comparison of seronegative and seropositive disease.

Authors:  P A Reilly; J Elswood; A Calin
Journal:  Br J Rheumatol       Date:  1988-04

2.  A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.

Authors:  I H Nuver-Zwart; P L van Riel; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.

Authors:  P J Prouse; D Shawe; J M Gumpel
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

4.  Seronegative rheumatoid arthritis: tell it as it is.

Authors:  W W Buchanan; D P Singal
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

5.  Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.

Authors:  M Farr; E J Tunn; D P Symmons; D G Scott; P A Bacon
Journal:  Br J Rheumatol       Date:  1989-04

6.  Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br J Rheumatol       Date:  1985-08

7.  Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.

Authors:  O H Nielsen
Journal:  Scand J Gastroenterol       Date:  1982-04       Impact factor: 2.423

8.  A comparison of patients with seropositive and seronegative rheumatoid arthritis.

Authors:  J Edelman; A S Russell
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

10.  An epidemiologically based follow-up study of recent arthritis. Incidence, outcome and classification.

Authors:  H A Isomäki
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

View more
  3 in total

Review 1.  Efficacy and toxicity of old and new disease modifying antirheumatic drugs.

Authors:  P Tugwell; V Welch; M Suarez-Almazor; B Shea; G Wells
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Sulfasalazine: a review of its use in the management of rheumatoid arthritis.

Authors:  Greg L Plosker; Katherine F Croom
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Sulfasalazine for rheumatoid arthritis.

Authors:  M E Suarez-Almazor; E Belseck; B Shea; G Wells; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2000
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.